| dbo:abstract |
Sucampo Pharmaceuticals, Inc. was a pharmaceutical company headquartered in Rockville, Maryland that focused on gastroenterology, ophthalmology, and oncology-related disorders. In 2018, the company was acquired by Mallinckrodt. Sucampo had two marketed products, Amitiza, which treats constipation issues and Rescula, which helps treat ocular hypertension and open-angle glaucoma. Takeda Pharmaceutical Company had a license to distribute Rescula globally except for in Japan and China. The company had two Phase III drugs in development for rare diseases — one for Niemann-Pick Type C and the other for familial adenomatous polyposis, which can cause colon cancer if untreated. (en) |
| dbo:assets |
5.2E8 (dbd:usDollar) |
| dbo:dissolutionDate |
2018-02-12 (xsd:date) |
| dbo:equity |
1.67E8 (dbd:usDollar) |
| dbo:fate |
Acquired byMallinckrodt (en) |
| dbo:foundingYear |
1996-01-01 (xsd:gYear) |
| dbo:headquarter |
dbr:Rockville,_Maryland |
| dbo:industry |
dbr:Pharmaceutical_industry |
| dbo:keyPerson |
dbr:CFO |
| dbo:netIncome |
1.8E7 (dbd:usDollar) |
| dbo:numberOfEmployees |
139 (xsd:nonNegativeInteger) |
| dbo:product |
dbr:Amitiza |
| dbo:revenue |
2.3E8 (dbd:usDollar) |
| dbo:wikiPageID |
44919158 (xsd:integer) |
| dbo:wikiPageLength |
4684 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1069885155 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Rockville,_Maryland dbr:Bethesda,_Maryland dbc:Pharmaceutical_companies_established_in_1996 dbr:Gastroenterology dbr:Phase_III_clinical_trials dbr:Mallinckrodt dbr:Pharmaceutical_industry dbc:2018_mergers_and_acquisitions dbc:American_companies_disestablished_in_2018 dbc:American_companies_established_in_1996 dbr:CEO dbr:Familial_adenomatous_polyposis dbr:Food_and_Drug_Administration dbr:Amitiza dbc:2018_disestablishments_in_Maryland dbr:Chairman dbr:Takeda_Pharmaceutical_Company dbc:1996_establishments_in_Maryland dbr:Ocular_hypertension dbr:Oncology dbr:Ophthalmology dbr:CFO dbr:Rescula dbr:Colon_cancer dbr:Niemann-Pick_Type_C dbr:Open-angle_glaucoma |
| dbp:assets |
5.2E8 (dbd:usDollar) |
| dbp:defunct |
2018-02-12 (xsd:date) |
| dbp:equity |
1.67E8 (dbd:usDollar) |
| dbp:fate |
Acquired by Mallinckrodt (en) |
| dbp:hqLocation |
dbr:Rockville,_Maryland |
| dbp:industry |
dbr:Pharmaceutical_industry |
| dbp:keyPeople |
Andrew P. Smith (en) Peter Greenleaf (en) |
| dbp:name |
Sucampo Pharmaceuticals, Inc. (en) |
| dbp:netIncome |
1.8E7 (dbd:usDollar) |
| dbp:numEmployees |
139 (xsd:integer) |
| dbp:products |
dbr:Amitiza |
| dbp:revenue |
2.3E8 (dbd:usDollar) |
| dbp:wikiPageUsesTemplate |
dbt:Authority_control dbt:Decrease dbt:End_date_and_age dbt:Increase dbt:Infobox_company dbt:Reflist dbt:Short_description dbt:Small dbt:Start_date_and_age |
| dct:subject |
dbc:Pharmaceutical_companies_established_in_1996 dbc:2018_mergers_and_acquisitions dbc:American_companies_disestablished_in_2018 dbc:American_companies_established_in_1996 dbc:2018_disestablishments_in_Maryland dbc:1996_establishments_in_Maryland |
| rdf:type |
owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 dbo:Organisation |
| rdfs:comment |
Sucampo Pharmaceuticals, Inc. was a pharmaceutical company headquartered in Rockville, Maryland that focused on gastroenterology, ophthalmology, and oncology-related disorders. In 2018, the company was acquired by Mallinckrodt. (en) |
| rdfs:label |
Sucampo Pharmaceuticals (en) |
| owl:sameAs |
freebase:Sucampo Pharmaceuticals yago-res:Sucampo Pharmaceuticals wikidata:Sucampo Pharmaceuticals http://arz.dbpedia.org/resource/ادوية_سوكامبو https://global.dbpedia.org/id/sMwu |
| skos:closeMatch |
http://www.grid.ac/institutes/grid.467571.6 http://www.grid.ac/institutes/grid.476760.4 |
| prov:wasDerivedFrom |
wikipedia-en:Sucampo_Pharmaceuticals?oldid=1069885155&ns=0 |
| foaf:isPrimaryTopicOf |
wikipedia-en:Sucampo_Pharmaceuticals |
| foaf:name |
Sucampo Pharmaceuticals, Inc. (en) |
| is dbo:wikiPageWikiLink of |
dbr:Unoprostone dbr:List_of_pharmaceutical_companies dbr:Lubiprostone dbr:Mallinckrodt dbr:Evermay |
| is foaf:primaryTopic of |
wikipedia-en:Sucampo_Pharmaceuticals |